Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

The microbe Pyrodictium abyssi is an archaeon—a member of what's known as the third domain of life—and an extremophile. It ...

I have spent years covering discoveries that nudge our origin story around the edges, but the sequencing of DNA from one of the very last Neanderthals does something different: it rewrites the center ...

Fluorogenic DNA aptamers produce light only in the correct structural state, enabling programmable molecular logic, ...

Single-cell sequencing provides unprecedented detail into cell-to-cell variability, uncovering key biological mechanisms in ...

Two centuries after Ludwig van Beethoven’s death, a few strands of his hair have given scientists their clearest view yet of what was happening inside his body. By sequencing DNA from authenticated ...

A new cfDNA-based blood test uses AI to detect bladder, prostate, and kidney cancers early, offering a faster, safer, and ...

Dr Ryan Magee graduates today with a PhD in Biological Sciences, having developed a faster, cheaper method to track a major ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

A small group of BYU nursing students traveled to Japan this summer with professor Ryan Rasmussen, graduate program ...

We have long struggled to determine how the first living organisms on Earth came together. Now, surprising evidence hints ...

Scientists trace the origins of human kissing back over 20 million years to ancient apes who first showed gentle ...